Swiss trial of decompressive craniectomy versus best medical treatment of spontaneous supratentorial intracerebral haemorrhage (SWITCH): an international, multicentre, randomised-controlled, two-arm, assessor-blinded trial
European Stroke Journal · 2024
DOI: 10.1177/23969873241231047 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Stroke Journal, 2024. Verfasst von Urs Fischer und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital and University of Bern, Bern, Switzerland. Hauptthemen laut MEDLINE: Cerebral Hemorrhage, Decompressive Craniectomy. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Boehringer Ingelheim, the Inselspital Stiftung.
Abstract (Originalsprache)
Rationale
Decompressive craniectomy (DC) is beneficial in people with malignant middle cerebral artery infarction. Whether DC improves outcome in spontaneous intracerebral haemorrhage (ICH) is unknown.
Aim
To determine whether DC without haematoma evacuation plus best medical treatment (BMT) in people with ICH decreases the risk of death or dependence at 6 months compared to BMT alone. Methods and design: SWITCH is an international, multicentre, randomised (1:1), two-arm, open-label, assessor-blinded trial. Key inclusion criteria are age ⩽75 years, stroke due to basal ganglia or thalamic ICH that may extend into cerebral lobes, ventricles or subarachnoid space, Glasgow coma scale of 8–13, NIHSS score of 10–30 and ICH volume of 30–100 mL. Randomisation must be performed <66 h after onset and DC <6 h after randomisation. Both groups will receive BMT. Participants randomised to the treatment group will receive DC of at least 12 cm in diameter according to institutional standards. Sample size: A sample of 300 participants randomised 1:1 to DC plus BMT versus BMT alone provides over 85% power at a two-sided alpha-level of 0.05 to detect a relative risk reduction of 33% using a chi-squared test. Outcomes: The primary outcome is the composite of death or dependence, defined as modified Rankin scale score 5–6 at 6 months. Secondary outcomes include death, functional status, quality of life and complications at 180 days and 12 months.
Discussion
SWITCH will inform physicians about the outcomes of DC plus BMT in people with spontaneous deep ICH, compared to BMT alone.
Trial registration
ClinicalTrials.gov Identifier: NCT02258919
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology, University Hospital and University of Bern, Bern, Switzerland.
- Department of Neurology, University Hospital and University of Basel, Basel, Switzerland.
- Department of Neurosurgery, University Hospital and University of Bern, Bern, Switzerland.
- Department of Neurosurgery, Medical Center University of Freiburg, Freiburg, Germany.
- CTU Bern, Department of Clinical Research, University of Bern, Bern, Switzerland.
- Department of Neurosurgery, University Medical Center Mainz, Germany.
ORCID-Profile: Urs Fischer, Werner Z'Graggen, Daniel Strbian, Rustam Al-Shahi Salman, Jenny Bressan, Heinrich P Mattle
Förderung
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Boehringer Ingelheim
- the Inselspital Stiftung
- Schweizerische Herzstiftung
Zitieren
APA
Fischer, U., Fung, C., Beyeler, S., Bütikofer, L., Z'Graggen, W., Ringel, F., Gralla, J., Schaller, K., Plesnila, N., Strbian, D., Arnold, M., Hacke, W., Jüni, P., Mendelow, A. D., Stapf, C., Al-Shahi Salman, R., Bressan, J., Lerch, S., Bassetti, C. L. A., …, & Beck, J. (2024). Swiss trial of decompressive craniectomy versus best medical treatment of spontaneous supratentorial intracerebral haemorrhage (SWITCH): an international, multicentre, randomised-controlled, two-arm, assessor-blinded trial. European Stroke Journal. https://doi.org/10.1177/23969873241231047
Vancouver
Fischer U, Fung C, Beyeler S, Bütikofer L, Z'Graggen W, Ringel F, et al. Swiss trial of decompressive craniectomy versus best medical treatment of spontaneous supratentorial intracerebral haemorrhage (SWITCH): an international, multicentre, randomised-controlled, two-arm, assessor-blinded trial. European Stroke Journal. 2024. doi:10.1177/23969873241231047
BibTeX
@article{Fischer2024,
author = {Fischer, Urs and Fung, Christian and Beyeler, Seraina and Bütikofer, Lukas and Z'Graggen, Werner and Ringel, Florian and Gralla, Jan and Schaller, Karl and Plesnila, Nikolaus and Strbian, Daniel and Arnold, Marcel and Hacke, Werner and Jüni, Peter and Mendelow, Alexander David and Stapf, Christian and Al-Shahi Salman, Rustam and Bressan, Jenny and Lerch, Stefanie and Bassetti, Claudio L A and Mattle, Heinrich P and Raabe, Andreas and Beck, Jürgen},
title = {Swiss trial of decompressive craniectomy versus best medical treatment of spontaneous supratentorial intracerebral haemorrhage (SWITCH): an international, multicentre, randomised-controlled, two-arm, assessor-blinded trial},
journal = {European Stroke Journal},
year = {2024},
doi = {10.1177/23969873241231047}
}
EUVIMED